Maho Shibata

ResearcherID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Development (Cambridge, England)

Oncogene

Cancer research

Expert opinion on therapeutic targets

The George Washington University

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The George Washington University Jun 01 2018

United States

Assistant Professor

Education History

Cornell University

United States

PHD :: Molecular Biology and Genetics

Publications

Sally W Feng, Tanya M North, Peri Wivell, Andrew Pletcher, Anastas Popratiloff, Maho Shibata
Macrophages of multiple hematopoietic origins reside in the developing prostate. Development (Cambridge, England) 151 (16) (2024)
Sally W Feng, Tanya M North, Peri Wivell, Andrew Pletcher, Anastas Popratiloff, Maho Shibata
Macrophages of multiple hematopoietic origins reside in the developing prostate. Development (Cambridge, England) 151 (16) (2024)
Sally W Feng, Tanya M North, Peri Wivell, Andrew Pletcher, Anastas Popratiloff, Maho Shibata
Macrophages of multiple hematopoietic origins reside in the developing prostate. Development (Cambridge, England) (2024)
Sally W Feng, Tanya M North, Peri Wivell, Andrew Pletcher, Anastas Popratiloff, Maho Shibata
Macrophages of multiple hematopoietic origins reside in the developing prostate. Development (Cambridge, England) (2024)
Sally W Feng, Tanya M North, Peri Wivell, Andrew Pletcher, Anastas Popratiloff, Maho Shibata
Macrophages of multiple hematopoietic origins reside in the developing prostate. Development (Cambridge, England) (2024)
Ashutosh S Yende, Emily C Williams, Andrew Pletcher, Alexandra Helfand, Helen Ibeawuchi, Tanya M North, Patricia S Latham, Anelia Horvath, Maho Shibata
TRIM28 promotes luminal cell plasticity in a mouse model of prostate cancer. Oncogene (2023)
Ashutosh S Yende, Emily C Williams, Andrew Pletcher, Alexandra Helfand, Helen Ibeawuchi, Tanya M North, Patricia S Latham, Anelia Horvath, Maho Shibata
TRIM28 promotes luminal cell plasticity in a mouse model of prostate cancer. Oncogene (2023)
Alessandro Vasciaveo, Juan Martin Arriaga, Francisca Nunes de Almeida, Min Zou, Eugene F Douglass, Florencia Picech, Maho Shibata, José Antonio Rodriguez-Calero, Simone de Brot, Antonina Mitrofanova, Chee Wai Chua, Charles Karan, Ronald Realubit, Sergey Pampou, Jaime Y Kim, Stephanie N Afari, Timur Mukhammadov, Luca Zanella, Eva Corey, Mariano J Alvarez, Mark A Rubin, Michael M Shen, Andrea Califano, Cory Abate-Shen
OncoLoop: A network-based precision cancer medicine framework. Cancer discovery (2022)
Andrew Pletcher, Maho Shibata
Prostate organogenesis. Development (Cambridge, England) 149 (12) (2022)
Kang Le, Jing Sun, Hunain Khawaja, Maho Shibata, Sanjay B Maggirwar, Mitchell Reed Smith, Mamta Gupta
Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis. Blood advances 5 (14) (2021)
Cai Bowen, Maho Shibata, Hailan Zhang, Sarah K Bergren, Michael M Shen, Edward P Gelmann
CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss. Cancer research 80 (21) (2020)
Tejashree Joglekar, Jianqing Lin, Maho Shibata
ONECUT2 is a novel target for treatment of castration-resistant prostate cancer. Expert opinion on therapeutic targets 24 (2) (2020)

Maho Shibata.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maho Shibata